FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/077510 [Registered on: 29/11/2024] Trial Registered Prospectively
Last Modified On: 29/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Anaesthetic gas Sevoflurane on blood vessel following aneurysmal subarachnoid hemorrhage, in patients receiving nimodipine, assessed by radiology imaging :a prospective randomized controlled trial  
Scientific Title of Study   Effect of Sevoflurane on vasospastic cerebral vasculature following aneurysmal sah, in patients receiving intra- arterial nimodipine, assessed by digital subtraction angiography :a prospective randomized controlled trial(SIAN-VCV trial)  
Trial Acronym  SIAN-VCV 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sk Ahadul Islam 
Designation  SR neuroanaesthesia  
Affiliation  Post Graduate Institute of medical education and research 
Address  Anaesthesia and intensive care,Post Graduate Institute of medical education and research,neheru hospital,chandigarh,sector 12

Chandigarh
CHANDIGARH
160012
Other 
Phone  9903249642  
Fax    
Email  dr.islamahadul@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Nidhi Bidyut Panda 
Designation  Professor  
Affiliation  Post Graduate Institute of medical education and research 
Address  Anaesthesia and intensive care,Post Graduate Institute of medical education and research,neheru hospital,chandigarh,sector 12

Chandigarh
CHANDIGARH
160012
India 
Phone  7087009525  
Fax    
Email  nidhibp@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sk Ahadul Islam 
Designation  SR neuroanaesthesia  
Affiliation  Post Graduate Institute of medical education and research 
Address  Anaesthesia and intensive care,Post Graduate Institute of medical education and research,neheru hospital,chandigarh,sector 12

Chandigarh
CHANDIGARH
160012
India 
Phone  9903249642  
Fax    
Email  dr.islamahadul@gmail.com  
 
Source of Monetary or Material Support  
Thesis Grant By Post Graduate Institute of Medical Education and Research, Chandigarh , India , PIN 160012 
 
Primary Sponsor  
Name  Director PGIMER 
Address  Post Graduate Institute of medical education and research,Nehru hospital,chandigarh,sector 12, Chandigarh , India pin 160012 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SK AHADUL ISLAM  POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH  DEPT OF ANAESTHESIA AND INTENSIVE CARE , 4TH FLOOR NEHRU HOSPITAL, SECTOR 12, CHANDIGARH,160012
Chandigarh
CHANDIGARH 
9903249642

dr.islamahadul@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Postgraduate institute of medical education and research chandigarh institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G00-G99||Diseases of the nervous system, (2) ICD-10 Condition: D80-D89||Certain disorders involving the immune mechanism, (3) ICD-10 Condition: G973||Intraoperative hemorrhage and hematoma of a nervous system organ or structure complicating a procedure, (4) ICD-10 Condition: G973||Intraoperative hemorrhage and hematoma of a nervous system organ or structure complicating a procedure, (5) ICD-10 Condition: G978||Other intraoperative and postprocedural complications and disorders of nervous system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  propofol  propofol dose of induction 1-2 mg/kg followed by maintenance dose 50-200 microgram/kg/min as intravenous infusion till the procedure end on the basis of target entropy 40-60.  
Intervention  Sevoflurane  Sevoflurane will be used in dose of 1- 1.3 MAC for induction and upto procedure completed. Effect on diameter of measure cerebral vessel will be noted by digital subtraction angiography.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Adults patients (age 18 yrs) with cerebral vasospasm following aneurysmal subarachnoid hemorrhage posted for intra-arterial nimodipine who are either unconscious,semiconscious,irritable or intubated and need for general anaesthesia for the procedure 
 
ExclusionCriteria 
Details  1. Patient or legal heir’s refusal for consent
2. Patient with H/O allergy to test drugs
3. Patient who received intraarterial Nimodipine previously.
4. Patients having deranged renal parameters
5. Patients with vasculitis.
6. Patient having hydrocephalus.
7. Patients having abnormal coagulation parameters
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Effect on diameter of major cerebral vessels ICA,MCA,ACA  Baseline before giving general anesthesia and after nimodipine administration 
 
Secondary Outcome  
Outcome  TimePoints 
1. To assess changes in Cerebral Arterio-Venous Transit Time which is a surrogate marker of the cerebral blood flow by DSA.
2. Cerebral blood flow velocity (SFV/DFV/MFV), Pulsatility Index (PI) and Lindegaard ratio measured by TCD, before the procedure, 1 hour and 24 hours after procedure. These parameters will be measured once daily again for 1-5 days after IA Nimodipine.
3. Total dose of intra-procedure nimodipine.
4. Requirement of additional doses of Intra-arterial nimodipine during ICU stay.

5. Development of cerebral infarction during ICU stay.
6. Neurological status of the patients at discharge by Modified Rankin score (mRS).

 
0 Days till discharge 
 
Target Sample Size   Total Sample Size="62"
Sample Size from India="62" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
subarachnoid hemorrhage following rupture of cerebral aneurysm is a life-threatening condition. Who survive many of them suffer from severe neurological and neurocognitive deficits. One of the most dangerous consequences of aneurysmal subarachnoid hemorrhage is cerebral vasospasm described as reversible constriction of cerebral blood vessels, mostly affecting major vessels of circle of  Willis . The effectiveness of oral and intra-arterial nimodipine in preventing and treating cerebral vasospasm and decreasing cerebral infraction is well established. Sevoflurane is a cerebral vasodilator. Digital subtraction angiography is a method by which direct vessel can be measured using electronic caliper. Previous study showed that effects of propofol and sevoflurane on cerebral vasculature in patients with aneurysmal subarachnoid hemorrhage using digital subtraction angiography and observed that sevoflurane has vasodilating properties compared to propofol in patients with aneurysmal subarachnoid hemorrhage  
Hypothesis is that sevoflurane has synergistic effect of vasodilation with that of intra-arterial nimodipine in patients with cerebral vasospasm following aneurysmal subarachnoid hemorrhage. The mean change in vascular diameter  from baseline during  nimodipine therapy will be greater under sevoflurane anesthesia than under propofol based anesthesia in patients presenting for intra-arterial nimodipine therapy for vasospasm following aneurysmal subarachnoid hemorrhage. 
Close